{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:50:18Z","timestamp":1793310618866,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.exppara.2019.107717","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T03:45:06Z","timestamp":1561002306000},"page":"107717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles"],"prefix":"10.1016","volume":"204","author":[{"given":"Nancy Abd-elkader","family":"Hagras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal Farahat","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda Fahmy","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervat Mostafa","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanaa Ibrahim","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermine Mogahed","family":"Fawzy Hussein Mogahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Mohamed","family":"Tolba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel Youssef","family":"Shehab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.exppara.2019.107717_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.parint.2017.08.007","article-title":"The effect of lopinavir\/ritonavir and lopinavir\/ritonavir loaded PLGA nanoparticles on experimental toxoplasmosis","volume":"66","author":"Abou-El-Naga","year":"2017","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.exppara.2019.107717_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"8","key":"10.1016\/j.exppara.2019.107717_bib3","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s00436-013-3466-4","article-title":"Improved antifilarial activity of ivermectin in chitosan\u2013alginate nanoparticles against human lymphatic filarial parasite","volume":"112","author":"Ali","year":"2013","journal-title":"Brugiamalayi. Parasitol. Res."},{"issue":"6","key":"10.1016\/j.exppara.2019.107717_bib4","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00436-017-5458-2","article-title":"Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications","volume":"116","author":"Assolini","year":"2017","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2019.107717_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/09273940600659740","article-title":"Reactivation of Toxoplasma retinochoroiditis under atovaquone therapy in an immunocompetent patient","volume":"14","author":"Baatz","year":"2006","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"4","key":"10.1016\/j.exppara.2019.107717_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.4269\/ajtmh.2009.80.583","article-title":"Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994\u20132006","volume":"80","author":"Beraud","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"5\u20136","key":"10.1016\/j.exppara.2019.107717_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1600-0463.2009.02453.x","article-title":"Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence","volume":"117","author":"Blader","year":"2009","journal-title":"APMIS"},{"issue":"3","key":"10.1016\/j.exppara.2019.107717_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2007.10.027","article-title":"Delivery systems to increase the selectivity of antibiotics in phagocytic cells","volume":"125","author":"Briones","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.exppara.2019.107717_bib9","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.05183-11","article-title":"Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis","volume":"56","author":"Chew","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.exppara.2019.107717_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1086\/339551","article-title":"Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237\/ANRS 039 Study","volume":"34","author":"Chirgwin","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.exppara.2019.107717_bib11","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.178.5.1465","article-title":"Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice","volume":"178","author":"Denkers","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.exppara.2019.107717_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vetpar.2004.09.005","article-title":"Toxoplasmosis \u2013 a waterborne zoonosis","volume":"126","author":"Dubey","year":"2004","journal-title":"Vet. Parasitol."},{"issue":"3","key":"10.1016\/j.exppara.2019.107717_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.exppara.2012.05.001","article-title":"Initial characterization of an autoclaved Toxoplasma vaccine in mice","volume":"131","author":"Eissa","year":"2012","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.exppara.2019.107717_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12639-014-0546-z","article-title":"The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice","volume":"40","author":"El Temsahy","year":"2016","journal-title":"J. Parasit. Dis."},{"issue":"1","key":"10.1016\/j.exppara.2019.107717_bib15","first-page":"185","article-title":"Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies","volume":"38","author":"El Zawawy","year":"2008","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"10.1016\/j.exppara.2019.107717_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exppara.2014.12.007","article-title":"Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis","volume":"149","author":"El-Zawawy","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2019.107717_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exppara.2014.05.005","article-title":"Chitosan and silver nanoparticles: promising anti-Toxoplasma agents","volume":"143","author":"Gaafar","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2019.107717_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1208\/s12248-009-9102-7","article-title":"Effects of drug transporters on volume of distribution","volume":"11","author":"Grover","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.exppara.2019.107717_bib19","first-page":"77","article-title":"Toxoplasma gondii: scanning electron microscopic study before and after treatment","volume":"2","author":"Hammouda","year":"1992","journal-title":"J. Trop. Med."},{"issue":"5","key":"10.1016\/j.exppara.2019.107717_bib20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00002030-200103300-00007","article-title":"Dose-escalation, phase I\/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS","volume":"15","author":"Jacobson","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.exppara.2019.107717_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/clinids\/22.2.268","article-title":"Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS","volume":"22","author":"Katlama","year":"1996","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.exppara.2019.107717_bib22","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.3390\/molecules17089207","article-title":"Real time anti-Toxoplasma gondii activity of an active fraction of Eurycomalongifolia root studied by in situ scanning and transmission electron microscopy","volume":"17","author":"Kavitha","year":"2012","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.exppara.2019.107717_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2009.09.004","article-title":"Biodegradation, biodistribution and toxicity of chitosan","volume":"62","author":"Kean","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.exppara.2019.107717_bib24","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.4049\/jimmunol.163.8.4503","article-title":"Il-15 prolongs the duration of CD8+ T-cell mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii","volume":"163","author":"Khan","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2019.107717_bib25","series-title":"A Simple Guide to IBM SPSS Statistics for Version 20.0","author":"Kirkpatrick","year":"2013"},{"key":"10.1016\/j.exppara.2019.107717_bib26","series-title":"Encyclopedia of Statistical Sciences","author":"Kotz","year":"2006"},{"issue":"4","key":"10.1016\/j.exppara.2019.107717_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7324\/JAPS.2015.50404","article-title":"Development and evaluation of chitosan based polymeric nanoparticles of an antiulcer drug lansoprazole","volume":"5","author":"Nagarajan","year":"2015","journal-title":"J. Appl. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.exppara.2019.107717_bib28","first-page":"228","article-title":"Nanoparticle: an overview of preparation and characterization","volume":"1","author":"Pal","year":"2011","journal-title":"J. Appl. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.exppara.2019.107717_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.exppara.2019.107717_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1701-2163(15)31053-7","article-title":"Toxoplasmosis in pregnancy: prevention, screening, and treatment","volume":"35","author":"Paquet","year":"2013","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.exppara.2019.107717_bib31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00436-012-2866-1","article-title":"Validity of silver, chitosan and curcumin nanoparticles as anti-Giardia agents","volume":"111","author":"Said","year":"2012","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.exppara.2019.107717_bib32","first-page":"1","article-title":"Development and characterization of chitosan nanoparticles containing erthromycinestolate","volume":"15","author":"Shende","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"1417","key":"10.1016\/j.exppara.2019.107717_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1098\/rstb.2001.1017","article-title":"Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii","volume":"357","author":"Sibley","year":"2002","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.exppara.2019.107717_bib34","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2147\/IJN.S158736","article-title":"Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain","volume":"13","author":"Teimouri","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"47","key":"10.1016\/j.exppara.2019.107717_bib35","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1016\/j.vaccine.2011.09.016","article-title":"Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B- and T-cell epitopes from Toxoplasma gondii antigens","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.exppara.2019.107717_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1017\/S1466252315000183","article-title":"Toxoplasma gondii: history and diagnostic test development","volume":"16","author":"Wyrosdick","year":"2015","journal-title":"Anim. Health Res. Rev."},{"key":"10.1016\/j.exppara.2019.107717_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.actatropica.2017.02.030","article-title":"Immunization with Toxoplasma gondii aspartic protease 3 increases survival time of infected mice","volume":"171","author":"Zhao","year":"2017","journal-title":"Acta Trop."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489419301420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489419301420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:26:10Z","timestamp":1758003970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489419301420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":37,"alternative-id":["S0014489419301420"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2019.107717","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2019.107717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107717"}}